[Corrigendum] MicroRNA‑23a inhibits endometrial cancer cell development by targeting SIX1

Li,Hong-Lin; Sun,Jun-Jie; Ma,Hui; Liu,Shen-Jia; Li,Na; Guo,Su-Jie; Shi,Yang; Xu,Yan-Ying; Qi,Zhi-Ying; Wang,Yu-Quan; Wang,Fang; Guo,Rui-Meng; Liu,Dong; Xue,Feng-Xia

doi:10.3892/ol.2023.14032

October-2023 Volume 26 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

October-2023 Volume 26 Issue 4

Full Size Image

Correction Open Access

[Corrigendum] MicroRNA‑23a inhibits endometrial cancer cell development by targeting SIX1

Authors:
- Hong-Lin Li
- Jun-Jie Sun
- Hui Ma
- Shen-Jia Liu
- Na Li
- Su-Jie Guo
- Yang Shi
- Yan-Ying Xu
- Zhi-Ying Qi
- Yu-Quan Wang
- Fang Wang
- Rui-Meng Guo
- Dong Liu
- Feng-Xia Xue
View Affiliations / Copyright

Affiliations: Department of Obstetrics and Gynecology, The Secondary Hospital of Tianjin Medical University, Tianjin 300211, P.R. China, Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China

Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 445
|
Published online on: August 29, 2023

https://doi.org/10.3892/ol.2023.14032
Expand metrics +

Article

Oncol Lett 18: [Related article:] 3792–3802, 2019; DOI: 10.3892/ol.2019.10694

Following the publication of the above article, an interested reader drew to the authors’ attention that, in Fig. 4D on p. 3797 showing the results of Transwell invasion assay experiments, sections of the ‘HEC1B/SIX1 con’ and ‘Ishikawa/SIX1 treated’ data panels were overlapping, such that these data appeared to have been derived from the same original source where the results of differently performed experiments were intended to have been shown. After having re-examined their original data, the authors realized that this figure had inadvertently been assembled incorrectly.

Figure 4.

Influence of SIX1 on the biological behavior of endometrial cancer cell lines. (A) SIX1 plasmid or siRNA were used to increase or reduce the protein expression levels of SIX1 in HEC1B or Ishikawa cells. Differences were detected using western blotting. Protein expression levels of SIX1 in HEC1B or Ishikawa cells were increased or reduced in the SIX1 plasmid or siRNA group compared with the control group, respectively. (B) Colony formation assay. The results of colony formation assay demonstrated that proliferation was significantly enhanced or weakened compared with the control in HEC1B or Ishikawa cells, respectively. Magnification, ×200. (C) Migration detected by wound healing assays. The results revealed significantly smaller or bigger width in the treated group compared with the control group in HEC1B or Ishikawa cells, respectively. (D) Invasion detected by Transwell assays. Significantly more or fewer invasive cells were observed in the treated group compared with in the control group in HEC1B or Ishikawa cells, respectively. Magnification, ×200. *P<0.05 vs. con. Con, control; siRNA, small interfering RNA; SIX1, sine oculis homeobox homolog 1; SIX1 treated, overexpression in the HEC1B cell line or knockdown in the Ishikawa cell line.

A revised version of Fig. 4, showing data from one of the repeated set of experiments for Fig. 4D, is shown on the next page. Note that the errors made in assembling this figure did not affect the overall conclusions reported in the paper. All the authors agree to the publication of this corrigendum, and they are grateful to the Editor of Oncology Letters for allowing them the opportunity to publish this. The authors also apologize to the readership for any inconvenience caused.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] MicroRNA‑23a inhibits endometrial cancer cell development by targeting SIX1

This article is mentioned in:

Article

Figure 4.

Related Articles